Study Title: A012301: LoTam: A Randomized, Phase III Clinical Trial of LowDose Tamoxifen for Selected Patients with Molecular Low-risk EarlyStage Breast Cancer
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Sivapiragasam, Abirami, at sivapira@musc.edu.Study Coordinator, Gelardi, Theresa, at gelardi@musc.edu.Self Regional Medical CenterAffiliate Principal Investigator, Metzner-Sadurski, Joanna, at jsadurski@selfregional.org.Study Coordinator, Blalock, Margaret, at margaret.bentley@selfregional.org.Trial opened at the following institutions: Self Regional Medical Center, Medical University of South Carolina